Funder: Sontag Foundation
Due Dates: January 12, 2026 (Portal opens) | March 18, 2026 (Application deadline, 11:59pm ET) | Fall 2026 (Awards announced)
Funding Amounts: $750,000 total ($150,000/year for 5 years; includes up to $19,500/year indirect costs)
Summary: Supports innovative research combining engineered NK cells and IL-12-expressing oncolytic virus to develop more effective, less toxic glioblastoma therapies.
Key Information: No citizenship requirement; applicants must hold first independent faculty appointment (March 1, 2021–January 1, 2026) at a US or Canadian non-profit institution.